Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 4,332 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Sunshine Biopharma Inc | SBFMW | NASDAQ | Equity Warrant |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0391 | 30.05% | 0.1692 | 23:00:08 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.1698 | 0.12 | 0.179 | 0.1692 | 0.1301 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
|---|---|---|---|---|
| 25 | 4,332 | 0.1687578 | 731 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 100 | 0.1692 | USD |
Sunshine Biopharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.34M | 25.68M | - | 24.09M | -4.51M | -0.18 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Sunshine Biopharma
| Date | Time | Source | Heading |
|---|---|---|---|
| 12/10/2024 | 15:26 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/14/2024 | 15:28 | Edgar (US Regulatory) | Form SC 13G/A - Statement of Beneficial Ownership by Certain.. |
| 11/12/2024 | 10:29 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 11/11/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 11/07/2024 | 15:40 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/06/2024 | 12:43 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
| 11/05/2024 | 15:05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 10/23/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/17/2024 | 15:05 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 9/10/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 6/11/2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 6/07/2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
SBFMW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). |
NASDAQ:SBFMW -
What is the current Sunshine Biopharma Inc share price?
The current share price of Sunshine Biopharma Inc is US$ 0.1692
How many Sunshine Biopharma Inc shares are in issue?
Sunshine Biopharma Inc has 25,678,000 shares in issue
What is the market cap of Sunshine Biopharma Inc?
The market capitalisation of Sunshine Biopharma Inc is USD 3.34M
What is the 1 year trading range for Sunshine Biopharma Inc share price?
Sunshine Biopharma Inc has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Sunshine Biopharma Inc?
The price to earnings ratio of Sunshine Biopharma Inc is -15.9
What is the cash to sales ratio of Sunshine Biopharma Inc?
The cash to sales ratio of Sunshine Biopharma Inc is 2.97
What is the reporting currency for Sunshine Biopharma Inc?
Sunshine Biopharma Inc reports financial results in USD
What is the latest annual turnover for Sunshine Biopharma Inc?
The latest annual turnover of Sunshine Biopharma Inc is USD 24.09M
What is the latest annual profit for Sunshine Biopharma Inc?
The latest annual profit of Sunshine Biopharma Inc is USD -4.51M
What is the registered address of Sunshine Biopharma Inc?
The registered address for Sunshine Biopharma Inc is 6500 TRANS-CANADA HIGHWAY 4TH FLOOR, POINTE-CLAIRE, QUEBEC, MONTREAL, QUEBEC, H9R 0A5
What is the Sunshine Biopharma Inc website address?
The website address for Sunshine Biopharma Inc is www.sunshinebiopharma.com
Which industry sector does Sunshine Biopharma Inc operate in?
Sunshine Biopharma Inc operates in the COML PHYSICAL, BIOLOGCL RESH sector
